RT @ilyapharma: First clinical trial with #ILP100 #emilimogene #sigulactibac published!
#RCT #Lancet #Discovery #eclinicalmedicine #ATMP #CGT #synbio #innovation #H2020 #EICAccelerator https://t.co/QU5Z0Ri8zn
🐦🔗: https://n.respublicae.eu/EUeic/status/1664527874638987264
#ILP100 #emilimogene #sigulactibac #RCT #Lancet #discovery #eclinicalmedicine #ATMP #CGT #synbio #innovation #H2020 #eicAccelerator